Copyright
©The Author(s) 2024.
World J Clin Oncol. Feb 24, 2024; 15(2): 195-207
Published online Feb 24, 2024. doi: 10.5306/wjco.v15.i2.195
Published online Feb 24, 2024. doi: 10.5306/wjco.v15.i2.195
Figure 2 IFNGR1 and JAK1/2 are downregulated in lung adenocarcinoma.
IFNGR1, IFNAR1, JAK1, and JAK2 expression in human lung adenocarcinoma (LUAD) tumors compared to normal tissue tumors. A-D: Selamat Lung dataset; E: The Cancer Genome Atlas from the University of ALabama at Birmingham CANcer data analysis Portal. Expression of IFNGR1 in LUAD based on the patient´s smoking habits. Reformed smoker 1 (< 5 years); Reformed smoker 2 (> 15 years). Results are considered significant (P < 0.05) in all cases, with the exception of IFNAR1 (NS: Not significant).
- Citation: Tecalco-Cruz AC, Medina-Abreu KH, Oropeza-Martínez E, Zepeda-Cervantes J, Vázquez-Macías A, Macías-Silva M. Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression. World J Clin Oncol 2024; 15(2): 195-207
- URL: https://www.wjgnet.com/2218-4333/full/v15/i2/195.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i2.195